Literature DB >> 23074431

Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review.

S Sehatzadeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23074431      PMCID： PMC3384373     

Source DB:  PubMed          Journal:  Ont Health Technol Assess Ser        ISSN： 1915-7398


× No keyword cloud information.
  45 in total

Review 1.  Influenza vaccine for patients with chronic obstructive pulmonary disease.

Authors:  P J Poole; E Chacko; R W B Wood-Baker; C J Cates
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Response to pneumococcal vaccine in chronic obstructive lung disease--the effect of ongoing, systemic steroid treatment.

Authors:  Johnna Steentoft; Helle Bossen Konradsen; John Hilskov; Gunnar Gislason; Jens Rikardt Andersen
Journal:  Vaccine       Date:  2005-09-26       Impact factor: 3.641

4.  Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-03-05

5.  Oral non-typable Haemophilus influenzae enhances physiological mechanism of airways protection.

Authors:  R L Clancy; M L Dunkley
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

6.  Influenza virus vaccination of patients with chronic lung disease.

Authors:  G J Gorse; E E Otto; C C Daughaday; F K Newman; C S Eickhoff; D C Powers; R H Lusk
Journal:  Chest       Date:  1997-11-05       Impact factor: 9.410

7.  Effectiveness of influenza vaccine in the community-dwelling elderly.

Authors:  Kristin L Nichol; James D Nordin; David B Nelson; John P Mullooly; Eelko Hak
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

8.  Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study.

Authors:  A L Davis; C P Aranda; G Schiffman; L C Christianson
Journal:  Chest       Date:  1987-08       Impact factor: 9.410

9.  Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.

Authors:  T M Govaert; G J Dinant; K Aretz; N Masurel; M J Sprenger; J A Knottnerus
Journal:  BMJ       Date:  1993-10-16

10.  Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

Authors:  Mark T Dransfield; Moon H Nahm; Meilan K Han; Sarah Harnden; Gerard J Criner; Fernando J Martinez; Paul D Scanlon; Prescott G Woodruff; George R Washko; John E Connett; Nicholas R Anthonisen; William C Bailey
Journal:  Am J Respir Crit Care Med       Date:  2009-06-25       Impact factor: 21.405
View more
  12 in total

Review 1.  Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).

Authors:  Giuseppe La Torre; Alice Mannocci; Rosella Saulle; Vittoria Colamesta; Angela Meggiolaro; Daniele Mipatrini; Alessandra Sinopoli
Journal:  Hum Vaccin Immunother       Date:  2016-04-22       Impact factor: 3.452

Review 2.  Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

Authors:  Julia Ae Walters; Joanne Ngie Qing Tang; Phillippa Poole; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

3.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

Review 4.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 5.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

6.  Community-acquired pneumonia: pneumococcal vaccine.

Authors:  Mark Loeb
Journal:  BMJ Clin Evid       Date:  2015-12-03

Review 7.  Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011.

Authors:  M Nikitovic; S Brener
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01

8.  Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease.

Authors:  Yan Li; Ying Ma; Zhijie An; Chenyan Yue; Yamin Wang; Yunqiu Liu; Xiaodong Yuan; Shuping Zhang; Ming Shao; Changgui Li; Keli Li; Zundong Yin; Liye Wang; Huaqing Wang
Journal:  Hum Vaccin Immunother       Date:  2021-05-13       Impact factor: 3.452

9.  Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.

Authors:  Massimo Andreoni; Laura Sticchi; Silvia Nozza; Loredana Sarmati; Andrea Gori; Marcello Tavio
Journal:  Hum Vaccin Immunother       Date:  2021-09-15       Impact factor: 4.526

10.  Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010-2012.

Authors:  Parvaiz A Koul; Umar H Khan; Romana Asad; Rubaya Yousuf; Shobha Broor; Renu B Lal; Fatimah S Dawood
Journal:  Influenza Other Respir Viruses       Date:  2015-01       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.